This study aimed to characterize novel NPC disease biomarkers in order to establish a set of biomarkers for NPC that are focused on interventions targeting the HSP system in NPC and the underlying cellular pathology of NPC, including altered NPC1/2 protein function and lipid metabolism. Here, HSP90B2P is linked to nasopharyngeal carcinoma.